Onderneming RepliCel Life Sciences Inc.
Aandelen
REPCF
CA76027P4006
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0428 USD | +4,99% | -.--% | -4,89% |
Vakgebied
Aantal werknemers: 1
Verkoop per activiteit
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Cell Replication Technology
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Verkoop per regio
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14-12-18 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Kevin McElwee
FOU | Founder | 54 | - |
David Kwok
DFI | Director of Finance/CFO | - | 16-08-23 |
David Hall
CHM | Chairman | 71 | 22-12-10 |
Ben Austring
COO | Chief Operating Officer | 41 | 28-11-22 |
Robert Buckler
BRD | Director/Board Member | 58 | 01-10-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 22-12-10 |
Peter Lewis
BRD | Director/Board Member | 69 | 27-05-11 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Robert Buckler
BRD | Director/Board Member | 58 | 01-10-14 |
Gary Boddington
BRD | Director/Board Member | 56 | 01-06-21 |
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14-12-18 |
Peter Lowry
BRD | Director/Board Member | 61 | 14-12-18 |
Jamie Mackay
BRD | Director/Board Member | - | 09-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 61 426 772 | 24 249 871 ( 39,48 %) | 0 | 39,48 % |
Bedrijfsgegevens
RepliCel Life Sciences, Inc.
570 Granville Street Suite 900
V6C 3P1, Vancouver
+604 248 8730
http://www.replicel.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,89% | 2,78 mln. | |
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers REPCF
- Onderneming RepliCel Life Sciences Inc.